Other Viruses Citation List:
February 4 - February 17, 2011
Human Cytomegalovirus
1. Benzimidazole Analogs Inhibit Human Herpesvirus 6. Prichard, M.N., S.L. Frederick, S. Daily, K.Z. Borysko, L.B. Townsend, J.C. Drach, and E.R. Kern. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21300829].
[Pubmed]. OV_0204-021711.
Herpes simplex virus
2. Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions to Inhibit Herpes Simplex Virus Type 1 Entry and Cell-to-Cell Spread. Lin, L.T., T.Y. Chen, C.Y. Chung, R.S. Noyce, T.B. Grindley, C. McCormick, T.C. Lin, G.H. Wang, C.C. Lin, and C.D. Richardson. Journal of Virology, 2011. [Epub ahead of print]; PMID[21307190].
[Pubmed]. OV_0204-021711.
3. In Vitro Cytotoxic and Antiviral Activities of Ficus Carica Latex Extracts. Lazreg Aref, H., B. Gaaliche, A. Fekih, M. Mars, M. Aouni, J. Pierre Chaumon, and K. Said. Natural Product Research, 2011. 25(3): p. 310-319; PMID[21294043].
[Pubmed]. OV_0204-021711.
Hepatitis B virus
4. Synthesis and Biological Assay of 4-Aryl-6-Chloro-Quinoline Derivatives as Novel Non-Nucleoside Anti-Hbv Agents. Guo, R.H., Q. Zhang, Y.B. Ma, X.Y. Huang, J. Luo, L.J. Wang, C.A. Geng, X.M. Zhang, J. Zhou, Z.Y. Jiang, and J.J. Chen. Bioorganic & Medicinal Chemistry, 2011. 19(4): p. 1400-1408; PMID[21292495].
[Pubmed]. OV_0204-021711.
Hepatitis C virus
5. Hepatitis C Ns5b Polymerase Inhibitors: Functional Equivalents for the Benzothiadiazine Moiety. Hutchinson, D.K., C.A. Flentge, P.L. Donner, R. Wagner, C.J. Maring, W.M. Kati, Y. Liu, S.V. Masse, T. Middleton, H. Mo, D. Montgomery, W.W. Jiang, G. Koev, D.W. Beno, K.D. Stewart, V.S. Stoll, A. Molla, and D.J. Kempf. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21316235].
[Pubmed]. OV_0204-021711.
6. Biliverdin and Heme Oxygenase Antiviral Activity against Hepatitis C Virus. Gutierrez-Grobe, Y., L. Vitek, C. Tiribelli, R.A. Kobashi-Margain, M. Uribe, and N. Mendez-Sanchez. Annals of hepatology : official journal of the Mexican Association of Hepatology, 2011. 10(1): p. 105-107; PMID[21301021].
[Pubmed]. OV_0204-021711.
7. Differential in Vitro Effects of Intravenous Versus Oral Formulations of Silibinin on the Hcv Life Cycle and Inflammation. Wagoner, J., C. Morishima, T.N. Graf, N.H. Oberlies, E. Teissier, E.I. Pecheur, J.E. Tavis, and S.J. Polyak. Plos One, 2011. 6(1): p. e16464; PMID[21297992].
[Pubmed]. OV_0204-021711.
8. Optimized High-Throughput Screen for Hepatitis C Virus Translation Inhibitors. Berry, K.E., B. Peng, D. Koditek, D. Beeman, N. Pagratis, J.K. Perry, J. Parrish, W. Zhong, J.A. Doudna, and I.H. Shih. Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening, 2011. 16(2): p. 211-220; PMID[21297107].
[Pubmed]. OV_0204-021711.